Proteomics-Powered
Preventive Health

Founder and core team bios, advisor profiles and affiliations, and scientific advisory board.

Recruiting tracker for early (seed-stage) hires and potential hires for an expanded team, post-seed.

Full programme management — 2 projects, milestones, study arms, budgets, contacts, deliverables, and live editing.

Searchable reference of 700+ validated and candidate protein biomarkers — AUC data, study populations, replication status, citations.

Evidence roadmap, key publications, and cohort infrastructure powering SYN-WAVE and SYN-DROME.

nELISA measurement architecture, competitive positioning, sample collection, lab infrastructure, and computational pipeline.

7 companies tracked — DTC omics, organ aging & longevity competitors; modality, price, threat assessment, and weekly events log.

Three converging markets: DTC longevity & molecular health ($3.6B), clinical molecular diagnostics ($18.85B), and the $86B precision medicine convergence by 2035.

$6M seed · 24-month runway · Full DTC product launch by Month 24 — personnel, platform, marketing & research. Lean version linked inside.

Unit economics and 5-year projections for the direct-to-consumer Nomic proteomics product.

11 risks tracked — likelihood/impact heat map, mitigations, owner, and status.

7 domain-expert AI personas — regulatory, assay science, population health, physician adoption, computational biology, market access, and commercial strategy — for structured strategic challenge across all three product lines.